Swiss biotech company Polyneuron inks funding
Polyneuron Pharmaceuticals AG, a Swiss biotech firm, has secured CHF22.5 million ($22.6 million) in Series A financing. The investors included Sofinnova Partners and New Enterprise Associates.
28 March 2019•1 min read
